When a 503B facility produces a copy of a branded drug, it engages in direct competition with the patent holder
Make sure you save this post for later
Common reasons include safety concerns, such as potential contamination or false labeling, and regulatory non-compliance, like missing certifications or violations of standards
Other contributing factors include: Small intestinal bacterial overgrowth (SIBO) Gastrointestinal infections or parasites Certain medicines that slow digestion (e.g., opioids, anticholinergics, tricyclic antidepressants, GLP-1 receptor agonists) Food intolerances or malabsorption disorders Swallowing excess air (aerophagia) Consumption of carbonated beverages Understanding the underlying cause is essential for effective management
Be sure to read the medication guide and patient information that comes with your medication
While clinical data shows semaglutide is generally well-tolerated, some patients report difficulty sleeping after starting the medication